Bringing the Oncology Community Together
In Prostate Cancer, Depression Means Less Treatment, Worse Outcomes
Men diagnosed with prostate cancer after being diagnosed with depression were less likely to undergo definitive treatment for their cancer and had worse overall survival.
Read More >>
The Cognitive Error Paradigm
Free Testosterone May Dictate Necessary Treatment in Prostate Cancer
AUA Adds Radium-223 to Treatment Guidelines for mCRPC
Giants of Cancer Care Heralded: Ceremony Honors 2nd Annual Giants Class
Advanced Prostate Cancer Clinics Keep Urologists, Patients Together
Radium-223, Abiraterone to be Studied in Combination
View More >>
- A Network of Your Peers
View more >>
Prognostic Biomarker Tests for Prostate Cancer
Dr. Freedland on the Association Between Carbohydrates and Prostate Cancer Risk
Antiandrogen Monotherapy for mCRPC
Most Popular Right Now
Tweets by @OncLive
Genomic Testing for Newly Diagnosed Low-Risk Prostate Cancer
E. David Crawford, MD, Steven E. Canfield, MD, Marc A. Dall'Era, MD, and Neal Shore, MD, discuss genomic testing for newly diagnosed, low-risk prostate cancer.
Updates in the Management of CRPC
Moderated by Raoul S. Concepcion, MD, this panel discussion includes expert perspectives from Neal D. Shore, MD, Paul R. Sieber, MD, E. David Crawford, MD, and Mark S. Austenfeld, MD.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.